Here, in this study, we conducted a comprehensive systematic review and meta-analysis to provide an up-to-date evaluation of semaglutide on efficacy and safety of weight loss, especially under the different administration situations, such as the weekly dosages, administration frequencies, trial durations, baseline obesity classifications and whether accompanied with lifestyle interventions
A., Skinner, J
CrossRef Clinical applications and advances in noninvasive prognostic assessment of metabolic dysfunction-associated steatotic liver disease Xin-Long He, Rui-Xu Yang, Jian-Gao Fan Hepatoma Research .2026;[Epub] CrossRef Association between chrononutrition patterns and metabolic dysfunction-associated steatotic liver disease in adolescents: a population-based study Yueju Wang, Mingxin Wang, Jingya He, Congwei You, Cai Tang, Lihong Zhu, Le Zhang, Xiaodie Yao Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity .2026;[Epub] CrossRef Outcome after liver transplantation: Predicting the unpredictable Ylenia Capraro, Leonard Lamfu, Martina Milana, Ilaria Lenci, Leonardo Baiocchi World Journal of Hepatology .2026;[Epub] CrossRef Letter to the Editor: Xietu Hemu prescription: A novel therapeutic strategy for obesity and metabolic dysfunction-associated steatotic liver disease

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists strengthened warnings on acute pancreatitis including necrotising and fatal cases